Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

Viol, Fabrice; Sipos, Bence; Fahl, Martina; Clauditz, Till S.; Amin, Tania; Kriegs, Malte; Nieser, Maike; Izbicki, Jakob R.; Huber, Samuel; Lohse, Ansgar W.; Schrader, Joerg

dc.contributor.author	Sipos, Bence
dc.date.accessioned	2023-05-22T10:04:10Z
dc.date.available	2023-05-22T10:04:10Z
dc.date.issued	2022
dc.identifier.issn	2211-3428
dc.identifier.uri	http://hdl.handle.net/10900/141302
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s13402-022-00727-z	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_00819
utue.publikation.seiten	1401-1419	de_DE
utue.personen.roh	Viol, Fabrice
utue.personen.roh	Sipos, Bence
utue.personen.roh	Fahl, Martina
utue.personen.roh	Clauditz, Till S.
utue.personen.roh	Amin, Tania
utue.personen.roh	Kriegs, Malte
utue.personen.roh	Nieser, Maike
utue.personen.roh	Izbicki, Jakob R.
utue.personen.roh	Huber, Samuel
utue.personen.roh	Lohse, Ansgar W.
utue.personen.roh	Schrader, Joerg
dcterms.isPartOf.ZSTitelID	Cellular Oncology	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	45	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE